Organigram Global Inc. (OGI) stock
OGINasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.68−0.03 (-4.29%)
Close on Nov 18, 2026Market cap $90.98MP/E –Yield –
Organigram Global operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -C$15.30M. The highest annual figure on record is C$36.42M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -C$15.30M | – |
| FY2022 | Aug 31, 2022 | -C$43.15M | – |
| FY2021 | Aug 31, 2021 | -C$91.82M | – |
| FY2020 | Aug 31, 2020 | -C$145.51M | -2751.9% |
| FY2019 | Aug 31, 2019 | C$5.49M | -84.9% |
| FY2018 | Aug 31, 2018 | C$36.42M | – |
See a number that looks wrong?